Insulin, Long-Acting

Known as: Long Acting Insulin, Insulin, Long-Acting [Chemical/Ingredient], Insulin, Long Acting 
Insulin formulations that contain substances that retard absorption thus extending the time period of action.
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2012
Highly Cited
2012
AIMS Insulin degludec (IDeg) is a new-generation, ultra-long-acting basal insulin that forms soluble multihexamers upon… (More)
Is this relevant?
2012
2012
The application of poly(hydroxybutyrate-co-hydroxyhexanoate) (PHBHHx) for sustained and controlled delivery of hydrophilic… (More)
  • table 2
  • figure 1
  • table 1
  • table 3
  • figure 2
Is this relevant?
Highly Cited
2009
Highly Cited
2009
AIM The Helping Evaluate Exenatide in overweight patients with diabetes compared with Long-Acting insulin (HEELA) study was… (More)
  • figure 1
  • table 1
  • figure 2
  • table 2
  • figure 3
Is this relevant?
Review
2009
Review
2009
AIM Basal insulin in type 1 diabetes can be provided using either NPH (Neutral Protamine Hagedorn) human insulin or long-acting… (More)
Is this relevant?
Review
2008
Review
2008
Insulin pump therapy (continuous subcutaneous insulin infusion [CSII]) is now an established form of intensive insulin treatment… (More)
  • table 1
  • figure 1
  • table 2
  • figure 2
  • figure 3
Is this relevant?
2005
2005
The primary therapeutic goal for the treatment of diabetes is maintenance of a long-term, near-normoglycemic condition and… (More)
  • figure 1
  • table 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2001
Highly Cited
2001
OBJECTIVE Glycemic control using inhaled, dry-powder insulin plus a single injection of long-acting insulin was compared with a… (More)
Is this relevant?
2001
2001
The aim of this study was to determine whether the long-acting insulin analog, insulin glargine, behaves like human insulin for… (More)
Is this relevant?
Highly Cited
2000
Highly Cited
2000
OBJECTIVE To study the pharmacodynamic properties of the subcutaneously injected long-acting insulin analog HOE901 (30 microg/ml… (More)
  • figure 1
  • figure 2
  • table 1
Is this relevant?
1999
1999
AIMS To compare the pharmacokinetic and pharmacodynamic properties of subcutaneously injected NN304, a novel long-acting insulin… (More)
Is this relevant?